Weekly update Companies AI-cruiter Recruiting

Sigilon Therapeutics

Sigilon Therapeutics

Founded: 2016

Location: Cambridge, MA

Employee range: 50 - 200

Clinical stage: RD

Therapy area: Diabetes (1)

Drug types: END, IMM, NEU, GEN, HEP

Lead product: SIG-002

Product link: http://sigilon.com/pipeline/

Funding: $145M IPO Dec 2020; $80M Mar 2020; $23.5M A Jun 2017

Short description:

Living Therapeutics

Drug notes:

SIG-XXX RD MPS-1, CNS condition; SIG-007 RD Fabry disease; SIG-018 RD MPS-2, CNS condition; SIG-020 RD MPS-6; undisclosed RD liver disease

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

Main

© 2024 Work In Biotech LLC

Terms of Service

Contact: recruit@workinbiotech.com